Navigation Links
Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
Date:3/8/2013

/a> a clinical collaboration agreement with Portola Pharmaceuticals, Inc. and Bayer HealthCare to evaluate an investigational-stage antidote for Factor Xa inhibitors. This proof-of-concept study is scheduled to complete in the second half of 2013.

On March 4, 2012, Janssen announced the U.S. Food and Drug Administration issued a second complete response letter regarding a supplemental New Drug Application for XARELTO® for the reduction of the risk of cardiovascular events in patients with acute coronary syndrome. Janssen is evaluating the letter and will respond to the agency's questions.

About XARELTO® (rivaroxaban)
XARELTO® works by blocking the blood clotting Factor Xa.  It is approved for six distinct uses:

  1. To reduce the risk of blood clots in the legs and lungs of people who have just had knee replacement surgery.
  2. To reduce the risk of blood clots in the legs and lungs of people who have just had hip replacement surgery.
  3. To reduce the risk of both hemorrhagic and thrombotic strokes as well as other blood clots in people with atrial fibrillation not caused by a heart valve problem. There is limited information on how XARELTO® compares to a medicine called warfarin in reducing the risk of stroke when the effects of warfarin are well controlled.
  4. To treat people with pulmonary embolism (PE).
  5. To treat people with deep vein thrombosis (DVT).
  6. To reduce the risk of recurrence of DVT or PE following an initial six months of treatment for acute venous thromboembolism.

Janssen Research & Development, LLC, and Bayer HealthCare together are developing rivaroxaban.  Janssen Pharmaceuticals, Inc. holds U.S.
'/>"/>

SOURCE Janssen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
3. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
4. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
5. West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
6. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
7. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
8. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
11. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
(Date:7/2/2015)... HOUSTON, TX and VANCOUVER , ... the "Company") (TSX-V: EPI) announced today that its common shares ... Capital Market ("NASDAQ") under the symbol "EPIX". ESSA ... Company will retain its listing on the TSX Venture Exchange ... the listing of the common shares on the NASDAQ, each ...
(Date:7/2/2015)... 2, 2015  Before you head outdoors with your family ... stay safe and healthy. Take steps to protect yourself from ... Protect Your Skin From the Sun ... increase your risk of skin cancer. To protect your skin ... possible, especially during midday hours. Wear a hat with a ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3
... CRDC ) today announced that Bernard A. Hausen, M.D., ... present a corporate overview and update at the following conferences: ... November 15, 2011 8:00 a.m. ET New York, NY ... 2011 9:30 a.m. New York, NY To access the ...
... 10, 2011 The Medical Oncology Association of ... recently signed an agreement to work together to ... quality and costs of cancer care in Southern ... clinical, reimbursement and distribution services to help health ...
Cached Medicine Technology:Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 2Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care 3
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part ... to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the ... , Almost every smartphone has an incredibly powerful camera built into it. And when ...
(Date:7/3/2015)... ... 03, 2015 , ... Every year, One-to-1 Fitness and the Red Deer ... the Red Deer community with free fitness training and indoor fitness boot camp classes ... and entertainment raised thousands of charity dollars and ended with a $10,000 donation to ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce ... first sweetFrog store located in Mississippi. The premium frozen yogurt chain was listed as ... store, located at 104 Railroad Avenue, New Albany, MS 38652, will have a grand ...
(Date:7/2/2015)... ... , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its ... in the Lone Star State. The premium frozen yogurt chain was listed as #22 ... which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American ... introduction of the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, ... this Act seeks to decrease drug overdose – especially of heroin and opioid ...
Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... therapies for some blood cancer patients, experts say , WEDNESDAY, ... three multiple myeloma whole genomes has been completed by U.S. ... understanding of this form of blood cancer and advance efforts ... more than 50 patient samples was conducted as part of ...
... ... Web community offers doctors and individuals the ability to interact, manage and share ... Skokie, Ill. (Vocus) ... company, is proud to announce the Beta launch, in Illinois, of its Web-based communication ...
... , , ... UM-JMH Center for Patient Safety has successfully launched a hand ... Michigan-based technology businesses who specialize in health care real-time locating ... is a health care RTLS systems integrator based in Farmington ...
... , , , ... best health care in the world, many Americans with the most ... from "alternative medicines." However, dermatologists caution that patients seeking alternative treatments ... by red, itchy rashes, risk developing more severe symptoms by delaying ...
... the University of Maryland Marlene and Stewart Greenebaum Cancer ... test positive for the human papillomavirus (HPV) have much ... virus, according to a new study in the journal ... that blacks in the study had a very low ...
... , MIAMI , July 29 ... an audience of press, travel agents, and other special guests, Celebrity Cruises, ... , , After buglers and a bagpipe and drum ... classic "Here Comes the Sun," Richard D. Fain, Chairman of Celebrity Cruises ...
Cached Medicine News:Health News:Multiple Myeloma Genome Unlocked 2Health News:Tabyat Partners, LLC. Launches iluvmydoc.com™, to Better Connect Patients with Doctors 2Health News:Michigan IT Companies Helping the University of Miami Center for Patient Safety Tackle a Leading Cause of Death Using an RTLS Solution to Monitor Staff Hand-Washing Compliance 2Health News:Michigan IT Companies Helping the University of Miami Center for Patient Safety Tackle a Leading Cause of Death Using an RTLS Solution to Monitor Staff Hand-Washing Compliance 3Health News:Alternative Therapies for Fighting Eczema Hold Promise, But Dermatologists Caution They Are No Substitute for Proven Medical Treatments 2Health News:Alternative Therapies for Fighting Eczema Hold Promise, But Dermatologists Caution They Are No Substitute for Proven Medical Treatments 3Health News:Low prevalence of HPV infection may be tied to poor prognosis for blacks with head and neck cancer 2Health News:Low prevalence of HPV infection may be tied to poor prognosis for blacks with head and neck cancer 3Health News:'Here Comes the Sun': Celebrity Equinox Named in Southampton 2Health News:'Here Comes the Sun': Celebrity Equinox Named in Southampton 3
Help restore pelvic muscle function with the Prometheus Pathway CTS 2000 evaluation and training system....
... catheters with secondary sensors placed in the ... test also provides information about acid control ... stomach or proximal esophageal acid exposure and ... Ability to record pH simultaneously in up ...
... advance of digital imaging technology, pathology ... digital formats, allowing for easier manipulation, ... in digital pathology imaging is analogous ... radiology, and which is continuing to ...
... SONOLINE G40 ultrasound system brings,the benefits ... entirely new level of diagnostic performance,and ... that meets your clinical needs. With ... and pulsed-wave Doppler capabilities,the G40 system ...
Medicine Products: